BRIEF published on 10/03/2024 at 22:22, 2 years 1 month ago Le fonds de revenu d'Asie-Pacifique Abrdn annonce l'émission d'actions privilégiées de série B Notation De Crédit Revenu Fixe Actions De Série B Stratégie De Levier Investissement En Asie-Pacifique
BRIEF published on 10/03/2024 at 22:19, 2 years 1 month ago Orange : Programme de rachat d’actions sans contrat de liquidité Stratégie D'entreprise Rachat D'actions Programme 2024 Orange Plans De Rémunération
BRIEF published on 10/03/2024 at 22:19, 2 years 1 month ago Orange: Share buyback program without liquidity contract Share Buyback Business Strategy Orange Compensation Plans Program 2024
BRIEF published on 10/03/2024 at 22:06, 2 years 1 month ago Redcare Pharmacy Reports Significant Growth in Q3 Rx Sales Customer Base Expansion Rx Sales Growth E-Rx Metrics Marketing Investment Non-Rx Sales
BRIEF published on 10/03/2024 at 22:06, 2 years 1 month ago Redcare Pharmacy rapporte une croissance significative des ventes de médicaments sur ordonnance au troisième trimestre Croissance Des Ventes De Médicaments Sur Ordonnance Mesures E-Rx Investissement En Marketing Ventes Sans Ordonnance Élargissement De La Clientèle
BRIEF published on 10/03/2024 at 22:06, 2 years 1 month ago Abivax recrute un premier patient pour son essai clinique sur la maladie de Crohn Biotechnologie Abivax Obefazimod Maladie De Crohn Essai Clinique
BRIEF published on 10/03/2024 at 22:06, 2 years 1 month ago Abivax recruits first patient for its clinical trial on Crohn's disease Biotechnology Abivax Obefazimod Clinical Trial Crohn's Disease
BRIEF published on 10/03/2024 at 22:02, 2 years 1 month ago Redcare Pharmacy Announces Significant Growth in German Rx Sales for Q3 Financial Guidance Germany Redcare Pharmacy Rx Sales Growth E-Rx Metrics
BRIEF published on 10/03/2024 at 22:02, 2 years 1 month ago Redcare Pharmacy annonce une croissance significative des ventes de médicaments sur ordonnance en Allemagne au troisième trimestre Allemagne Pharmacie Redcare Orientation Financière Croissance Des Ventes De Médicaments Sur Ordonnance Métriques E-Rx
BRIEF published on 10/03/2024 at 21:40, 2 years 1 month ago CFI Publie son Rapport Financier Semestriel 2024 Rapport Financier Investisseurs 2024 Marchés Financiers CFI
Published on 11/14/2026 at 12:56, 1 day 4 hours ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 15 hours ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 16 hours ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 16 hours ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 17 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 17 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 19 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 22 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 22 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 2 days 5 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 2 days 5 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 2 days 9 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 17 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
